Published September 1, 2022 | Version v1

Long term results after bariatric surgery

Authors/Creators

  • 1. University Hospital Center Albacete

Description

Bariatric surgery has proved its efficacy in the treatment of morbid obesity. The decrease of body weight is progressive, clinically significant and sustainable in relatively high percentage of patients. Most comorbidities resolve, thus the quality of life is improvedand the life expectancy increases.
This literature review aimed evaluation of 10-year or longer follow-up of patients who underwentvarious bariatric surgical procedures with a focus on long-term weight loss results and their clinical impact.
The percentage of Excesive Body Mass Index Loss (%EBMIL) and the percentage of Excessive Weight Loss (%EWL) are the basic indicators for evaluating the long term results after surgery. These indicators are used for discussing the characteristics and advantages of different procedures such as Roux-en-Y Gastric Bypass, Bilio-pancreatic Diversion, Scopinaro type, Duodenal Switch, Adjustable Gastric Band, Laparoscopic Sleeve Gastrectomy as a single procedure or augmented by a malabsorbtive component Single Anastomosis Duodeno Ileal-with Sleeve, Vertical Band Gastroplasty. Results are analyzed in long-term aspects as well as indications and incidence rates of re-operations are presented and analyzed.

Abstract (Bulgarian)

Бариатричната хирургия се счита за ефективно лечение на болестното затлъстяване с приемливи нива на усложнения, устойчиви дългосрочни резултати за загуба и поддръжка на телесното тегло, като увеличава и продължителността на живота на оперираните болни.
Настоящият литературен обзор е насочен към оценка на дългосрочната загуба на телесно тегло, поддръжката му във времето и клиничното му въздействие при пациентите, претърпели различни хирургични бариатрични операции, с дългосрочно проследяване на резултатите за период ≥ 10 години.
Процентната загубата на Ексцесивен Индекс на Tелесна Mаса (% Excesive Body Mass Index Loss= % EBMIL) и загуба на Ексцесивно Телесно Тегло (% Excessive Weight Loss= % EWL) са показатели, които се използват за оценка на дългосрочния ефект от процедурата. Чрез тези показатели се оценяват и дискутират предимствата на различните техники - Roux-en-Y gastricbypass, билио-панкреатичната деривация тип Scopinaro, билио-панкреатичната деривация с дуоденално превключване, Adjustable Gastric Band, Laparoscopic Sleeve Gasterctomy самостоятелно и с добавяне на малабсорбтивен елемент, като Single Anastomosis Duodeno-Ileal with Sleeve, Vertical Band Gastroplasty. Разгледани са резултатите в дългосрочен аспект, както и индикациите за ре-операции и тяхната честота.

Files

v86i3-1.pdf

Files (998.7 kB)

Name Size
md5:6a2dc8397b7ae3360a50424ae40a67e1
998.7 kB Preview Download

Additional details

Additional titles

Translated title (Bulgarian)
Дългосрочни резултати след бариатрична хирургия

Dates

Issued
2022-09-01

References

  • 1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: A systematic review and meta-analysis. Vol. 292, Journal of the American Medical Association. 2004. p.1724–37.
  • 2. Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: A systematic review. Vol. 312, JAMA - Journal of the American Medical Association. American Medical Association; 2014. p. 934–42.
  • 3. O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Metaanalysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg. 2019;29(1):3–14.
  • 4. Wood GC, Benotti PN, Lee CJ, Mirshahi T, Still CD, Gerhard GS, et al. Evaluation of the Association Between Preoperative Clinical Factors and Longterm Weight Loss After Roux-en-Y Gastric Bypass. JAMA Surg [Internet]. 2016 Nov 1 [cited 2020 Apr 15];151(11):1056. Available from: http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/jamasurg.2016.2334
  • 5. Coleman KJ, Huang YC, Hendee F, Watson HL, Casillas RA, Brookey J. Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system. Surg Obes Relat Dis [Internet]. 2014 [cited 2020 May 5];10(3):396–403. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24951065
  • 6. Neto RML, Herbella FAM, Tauil RM, Silva FS, de Lima SE. Comorbidities Remission After Rouxen-Y Gastric Bypass for Morbid Obesity is Sustained in a Long-Term Follow-up and Correlates with Weight Regain. Obes Surg [Internet]. 2012 Aug;22(10):1580–5. Available from: https://doi.org/10.1007%2Fs11695-012-0731-z
  • 7. Valezi AC, Junior JM, De Menezes MA, De Brito EME, De Souza SAF. Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up. Obes Surg. 2010 Nov;20(11):1491–5.
  • 8. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741–52.
  • 9. Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, et al. Duodenal switch: Long-term results. Obes Surg. 2007 Nov;17(11):1421–30.
  • 10. Scopinaro N. Thirty-five years of biliopancreatic diversion: Notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Vol. 22, Obesity Surgery. 2012. p. 427–32.
  • 11. Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS, Weidenbacher HJ, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55.
  • 12. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, et al. Health benefits of gastric bypass surgery after 6 years. JAMA - J Am Med Assoc. 2012 Sep 12;308(11):1122–31.
  • 13. Mantziari S, Dayer A, Duvoisin C, Demartines N, Allemann P, Calmes JM, et al. Long-Term Weight Loss, Metabolic Outcomes, and Quality of Life at 10 Years After Roux-en-Y Gastric Bypass Are Independent of Patients' Age at Baseline. Obes Surg. 2020;30(4):1181–8.
  • 14. Arman GA, Himpens J, Dhaenens J, Ballet T, Vilallonga R, Leman G. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016 Dec 1;12(10):1778–86.
  • 15. Ivanov Stoyanov T., Cascales Sanchez P., Prat Calero A., Martinez Moreno A., Garcia Blazquez E., Usero Rebollo S., Tonchev P., Ivanov K., Stoikov D. CSP. Resultados de pérdida de peso a largo plazo, en pacientes obesos mórbidos sometidos a derivación biliopancreática con cruce duode. BMI Bariatrica Metab Ibero Lat. 2016;2(3):1219–27.
  • 16. Marceau P, Biron S, Marceau S, Hould FS, Lebel S, Lescelleur O, et al. Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion. Obes Surg. 2015 Sep 3;25(9):1584–93.
  • 17. Topart P, Becouarn G, Delarue J. Weight Loss and Nutritional Outcomes 10 Years after Biliopancreatic Diversion with Duodenal Switch. Obes Surg. 2017 Jul 1;27(7):1645–50.
  • 18. Froylich D, Abramovich TS, Fuchs S, Zippel D, Hazzan D. Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty. Obes Surg. 2020;1808–13.
  • 19. Noria SF, Grantcharov T. Biological effects of bariatric surgery on obesity-related comorbidities. Vol. 56, Canadian Journal of Surgery. Canadian Medical Association; 2013. p. 47–57.
  • 20. Duce Martín A. Cirugía de la Obesidad Mórbida. Ediciones A, editor. Madrid 2007. Ediciones. Madrid; 2007.
  • 21. Chang J, Wittert G. Effects of bariatric surgery on morbidity and mortality in severe obesity. Vol. 7, International Journal of Evidence-Based Healthcare. Lippincott Williams and Wilkins; 2009. p. 43–8.